Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11 beta-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice

Autor: Zoi Michailidou, Brian R. Walker, Nicholas M. Morton, John P. Iredale, Sophie Turban, Patrick W. F. Hadoke, Jonathan R. Seckl, Xiantong Zou, Peter J. Ratcliffe, Joerg Schrader, Eileen Miller
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Male
Vascular Endothelial Growth Factor A
Angiogenesis
Adipose tissue
Weight Gain
Biochemistry
Mice
0302 clinical medicine
Transforming Growth Factor beta
11β-hydroxysteroid dehydrogenase type 1
Fibrosis
11-beta-Hydroxysteroid Dehydrogenase Type 1
Hypoxia
Mice
Knockout

Extracellular Matrix Proteins
0303 health sciences
biology
Molecular Bases of Disease
3. Good health
Apelin
Adipose Tissue
Fibroblast
Intercellular Signaling Peptides and Proteins
Collagen
Signal Transduction
medicine.medical_specialty
Adipose tissue macrophages
Neovascularization
Physiologic

Adipokine
030209 endocrinology & metabolism
Angiopoietin-like 4 Protein
03 medical and health sciences
Adipokines
Internal medicine
medicine
Angiopoietin-Like Protein 4
Animals
Obesity
Smad3 Protein
Glucocorticoids
Molecular Biology
030304 developmental biology
Cell Biology
Hypoxia-Inducible Factor 1
alpha Subunit

medicine.disease
Actins
PPAR gamma
Endocrinology
biology.protein
Insulin Resistance
Angiopoietins
Zdroj: Journal of Biological Chemistry; Vol 287
The Journal of Biological Chemistry
Michailidou, Z, Turban, S, Miller, E, Zou, X, Schrader, J, Ratcliffe, P J, Hadoke, P W F, Walker, B R, Iredale, J P, Morton, N M & Seckl, J R 2012, ' Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice ', Journal of Biological Chemistry, vol. 287, no. 6, pp. 4188-4197 . https://doi.org/10.1074/jbc.M111.259325
ISSN: 1083-351X
DOI: 10.1074/jbc.M111.259325
Popis: Background: Adipose hypertrophy limits fat cell oxygenation, promotes scarring, and associates with increased local glucocorticoid regeneration (higher 11βHSD1 enzyme). Results: 11βHSD1 knock-out mice have reduced scarring and better vascularization and oxygenation in their adipose tissue. Conclusion: Elevated adipose 11βHSD1 contributes to obesity pathogenesis by suppressing adipose angiogenesis. Significance: Enhancement of adipose oxygenation and vascularization is a novel therapeutic modality for 11βHSD1 inhibitors.
In obesity, rapidly expanding adipose tissue becomes hypoxic, precipitating inflammation, fibrosis, and insulin resistance. Compensatory angiogenesis may prevent these events. Mice lacking the intracellular glucocorticoid-amplifying enzyme 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1−/−) have “healthier” adipose tissue distribution and resist metabolic disease with diet-induced obesity. Here we show that adipose tissues of 11βHSD1−/− mice exhibit attenuated hypoxia, induction of hypoxia-inducible factor (HIF-1α) activation of the TGF-β/Smad3/α-smooth muscle actin (α-SMA) signaling pathway, and fibrogenesis despite similar fat accretion with diet-induced obesity. Moreover, augmented 11βHSD1−/− adipose tissue angiogenesis is associated with enhanced peroxisome proliferator-activated receptor γ (PPARγ)-inducible expression of the potent angiogenic factors VEGF-A, apelin, and angiopoietin-like protein 4. Improved adipose angiogenesis and reduced fibrosis provide a novel mechanism whereby suppression of intracellular glucocorticoid regeneration promotes safer fat expansion with weight gain.
Databáze: OpenAIRE